Extended-release niacin or ezetimibe and carotid intima-media thickness.

By Allen J. Taylor, T. Villines, E. Stanek, P. Devine, Len Griffen, Michael Miller, N. Weissman, M. Turco. New England Journal of Medicine, 2009

680 citations recorded by the source corpus.

Subfields: Cancer Research, Endocrinology, Diabetes and Metabolism, Surgery

View Paper: https://www.semanticscholar.org/paper/b32d0716b7af7ecfb23d640ce9b191205624f846

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Endocrinology, Diabetes and Metabolism

1. Christian Weber
2. H. Noels

Citations in the corpus

• Guidelines for the Primary Prevention of Stroke (2011, neutral): “001).(180) The rate of major cardiovascular”
• Atherosclerosis: current pathogenesis and therapeutic options (2011, background): “In statin-treated patients with low HDL cholesterol, shifting the lipid balance in favor of HDL cholesterol by extended release of nicotinic acid (niacin) has been exploited to achieve regression of carotid intima-media thickness, although this is probably owing to anti-inflammatory effects through ”